Literature DB >> 20692484

Risk factors for Banff borderline acute rejection in protocol biopsies and effect on renal graft function.

E H Espinoza1, C González-Parra, D M Macías-Díaz, N O Uribe-Uribe, J Alberú, L E Morales-Buenrostro.   

Abstract

INTRODUCTION: The interpretation and handling of Banff borderline acute rejection observed in protocol biopsies from patients with stable renal function continues to be controversial. Our objective was to identify the risk factors for borderline acute rejection on 1-year protocol biopsies and to evaluate their effect on renal graft function after 2 years' follow-up.
METHODS: We included 82 kidney transplant recipients (KTR), who underwent 1-year protocol biopsies with normal or stable graft function. All KTR had follow-up of at least 2 years posttransplantation. We formed three groups: (1) KTR with a normal biopsy, (2) KTR with borderline changes, and (3) KTR with interstitial fibrosis/tubular atrophy (IF/TA). We searched for risk factors related to borderline injury. The main outcome to evaluate was renal function at 1 month, at protocol biopsy, and 2 years posttransplant.
RESULTS: The 82 patients included in this study showed no differences in immunosuppression, gender, etiology of renal failure, or percentage of panel-reactive antibodies. The risk factors associated with borderline lesions were: at least one biopsy due to allograft dysfunction and acute rejection events during the first year posttransplant (P = .011 and P = .021, respectively). Increased serum creatinine and estimated glomerular filtration rate decline were greater among the borderline lesion than the normal group, but similar to patients with IF/TA.
CONCLUSION: Renal function decline was greater among borderline and IF/TA groups. However, the sum of insults, and not only the borderline injury itself, produces greater declines in renal function with greater risk for graft loss. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20692484     DOI: 10.1016/j.transproceed.2010.05.008

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

1.  The Outcome of Tapered Steroid Regimen When Used to Treat Acute Borderline Cellular Rejection After Kidney Transplant: A Single-Center Experience.

Authors:  Abdullah Jebrini; Ana Cecilia Farfan Ruiz; Meray Hosni; Tambi Jarmi
Journal:  J Clin Med Res       Date:  2022-09-29

2.  Clinical Relevance of Corticosteroid Withdrawal on Graft Histological Lesions in Low-Immunological-Risk Kidney Transplant Patients.

Authors:  Domingo Hernández; Juana Alonso-Titos; Teresa Vázquez; Myriam León; Abelardo Caballero; María Angeles Cobo; Eugenia Sola; Verónica López; Pedro Ruiz-Esteban; Josep María Cruzado; Joana Sellarés; Francesc Moreso; Anna Manonelles; Alberto Torío; Mercedes Cabello; Juan Delgado-Burgos; Cristina Casas; Elena Gutiérrez; Cristina Jironda; Julia Kanter; Daniel Serón; Armando Torres
Journal:  J Clin Med       Date:  2021-05-07       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.